Microtransplantation in Older Patients With Acute Myeloid Leukemia
NCT ID: NCT02831192
Last Updated: 2016-07-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
150 participants
INTERVENTIONAL
2006-05-31
2015-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Efficacy Study of Microtransplantation to Treat Elderly Acute Myeloid Leukemia
NCT02171117
HLA-mismatched Microtransplantation for High Risk Acute Myeloid Leukemia
NCT01484171
Hematopoietic Stem Cell Microtransplantation for in AML
NCT02676856
Micro-transplantation in Elderly Patients With Acute Myeloid Leukemia
NCT03439371
Efficacy of Integrated Induction-Consolidation Chemotherapy and Transplantation for Adult Acute Myeloid Leukemia: Multicenter Study
NCT07108530
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MST（microtransplantation）
microtransplantation
HLA mismatched donor mobilized prepheral stem cell infusion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
microtransplantation
HLA mismatched donor mobilized prepheral stem cell infusion
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age 60-90
* have HLA mismatched donor
Exclusion Criteria
* patient refused to accept donor cells
60 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
AI huisheng, MD
Role: STUDY_CHAIR
Affiliated Hospital of Academy of Military Medical Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Affiliated Hospital of Academy of Military Medical Sciences ,
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EAML-MST
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.